Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2026-02-26 @ 11:04 AM
Study NCT ID:
NCT02131493
Status:
COMPLETED
Last Update Posted:
2022-03-02
First Post:
2014-05-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
S-1 and and Gemcitabine vs Gemcitabine Alone as Adjuvant Chemotherapy for Patients With Resected Pancreatic Cancer
Sponsor:
Zhejiang University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ZYYYMedOncoPAC01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None